(Q39933423)

English

Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials

scientific article published on May 2010

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

0 references

Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Geoffrey A. Donnan

13

0 references

8

0 references

object named as

G Byrnes

26

0 references

Christopher Levi

object named as

C Levi

24

0 references

4

object named as

Thomas G Brott

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

1 reference

ORCID Public Data File 2021

Helle K Iversen

1 reference

ORCID Public Data File 2021

5

object named as

Danilo Toni

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

6

object named as

James C Grotta

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

author name string

Kennedy R Lees

1

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Erich Bluhmki

2

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Rüdiger von Kummer

3

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Gregory W Albers

7

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

John R Marler

9

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Scott A Hamilton

10

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Barbara C Tilley

11

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Stephen M Davis

12

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Werner Hacke

14

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

ECASS, ATLANTIS, NINDS and EPITHET rt-PA Study Group

15

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Kathryn Allen

16

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Jochen Mau

17

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Dieter Meier

18

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Gregory del Zoppo

19

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

D A De Silva

20

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

K S Butcher

21

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

M W Parsons

22

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

P A Barber

23

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

C Bladin

25

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

language of work or name

0 references

publication date

1 May 2010

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

375

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

9727

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

1695-1703

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Tissue plasminogen activator for acute ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960491-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960491-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960491-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960491-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The rtPA (alteplase) 0- to 6-hour acute stroke trial, part A (A0276g) : results of a double-blind, placebo-controlled, multicenter study. Thromblytic therapy in acute ischemic stroke study investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960491-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960491-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960491-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960491-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Thrombolysis with alteplase 3-4.5 h after acute ischaemic stroke (SITS-ISTR): an observational study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960491-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Pilot randomized trial of tissue plasminogen activator in acute ischemic stroke. The TPA Bridging Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960491-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Measurements of acute cerebral infarction: a clinical examination scale

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960491-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Interobserver agreement for the assessment of handicap in stroke patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960491-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960491-6

7 January 2021

based on heuristic

inferred from DOI database lookup

NXY-059 for acute ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960491-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Early stroke treatment associated with better outcome: the NINDS rt-PA stroke study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960491-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Number needed to treat to benefit and to harm for intravenous tissue plasminogen activator therapy in the 3- to 4.5-hour window: joint outcome table analysis of the ECASS 3 trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960491-6

7 January 2021

based on heuristic

inferred from DOI database lookup

After European Cooperative Acute Stroke Study 3: mission accomplished?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960491-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Metalloproteinase inhibition reduces thrombolytic (tissue plasminogen activator)-induced hemorrhage after thromboembolic stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960491-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion-diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960491-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute stroke triage to intravenous thrombolysis and other therapies with advanced CT or MR imaging: pro MR imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960491-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute stroke triage to intravenous thrombolysis and other therapies with advanced CT or MR imaging: pro CT.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960491-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Ultrasound-Enhanced Systemic Thrombolysis for Acute Ischemic Stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960491-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The combined approach to lysis utilizing eptifibatide and rt-PA in acute ischemic stroke: the CLEAR stroke trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960491-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Argatroban tPA stroke study: study design and results in the first treated cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960491-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Methodology of the Interventional Management of Stroke III Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960491-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Prehospital neuroprotective therapy for acute stroke: results of the Field Administration of Stroke Therapy-Magnesium (FAST-MAG) pilot trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960491-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(10)60491-6

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39933423&oldid=2120253464"